Innoup Farma S.L.

Food Allergy Immunotherapy

Innoup Farma S.L. is active in clinical research for peanut allergy, with a focus on oral treatment approaches designed to address allergic sensitivity and long-term tolerability in affected patients.

  • Peanut allergy
  • Oral immunotherapy
  • Safety and tolerability
  • Repeated-dose treatment

The company’s work in this area centers on defining clinically relevant treatment options for allergic disease management.

Oncology

The sponsor also funds research in advanced solid tumors, reflecting interest in therapeutic development for patients with difficult-to-treat malignancies.

  • Advanced solid tumors
  • Anticancer therapy
  • Clinical safety evaluation
  • Pharmacokinetics

This oncology activity indicates involvement in early clinical assessment of new treatment candidates for cancer care.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Tolerability of INP20 for Peanut Allergy in Patients

    Not yet recruiting

    2 1 1
    Spain